ASCO in Action

ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.

To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.

Tune in to the ASCO in Action podcast series for analysis and commentary on cancer policy and practice issues. The podcast is available through iTunes or Google Play.

Showing results for Policy

June 30, 2020

The Centers for Medicare & Medicaid Services (CMS) recently announced flexibilities for clinicians participating in the 2020 Quality Payment Program (QPP) Merit-based Incentive Payment System (MIPS) who have been impacted by the COVID-19 Public Health Emergency (PHE). Affected clinicians may submit an Extreme & Uncontrollable Circumstances Application to reweight any MIPS performance categories or may apply for the MIPS Promoting Interoperability Performance Category Hardship Exception.

June 23, 2020

On June 23, 2020, JCO: Oncology Practice published an article on rural cancer care as part of the State of Cancer Care in America series. "Closing the Rural Cancer Care Gap: Three Institutional Approaches," draws from the second event in the State of Cancer Care in America series and supporting literature to summarize the challenges to delivering high-quality care in rural communities, highlight institutional approaches to addressing these challenges, and update ASCO’s rural workforce data.

May 19, 2020

ASCO released the ASCO Special Report: A Guide to Cancer Care Delivery During the COVID-19 Pandemicwhich provides detailed guidance to oncology practices on the immediate and short-term steps that could be taken to help protect the safety of patients and healthcare staff before resuming more routine care operations during the COVID-19 public health crisis.

May 12, 2020

In the midst of the COVID-19 pandemic, a new ASCO article reports that oncology research programs are experiencing delays and other challenges in advancing clinical trials during this unprecedented time. The article, which published today in JCO Oncology Practice and was previewed during ASCO’s recent presscast on COVID-19 and cancer care, looks at the types of changes and challenges to clinical trials that research sites experienced early in the pandemic. Data from the article comes from a March 2020 survey of oncology research programs, including both academic- and community-based research programs.

April 23, 2020

The American Society of Clinical Oncology (the Society) and its affiliate organization the Association for Clinical Oncology (the Association) today announced the results of a survey that tracked the initial impact of the COVID-19 pandemic on cancer clinical trials, highlighted a new research initiative to address the data gap on the coronavirus’ effect on individuals with cancer, and set forth a road to recovery as the cancer care delivery system prepares for life after COVID-19.

April 22, 2020

WHAT: The U.S. cancer care delivery system is facing unprecedented challenges during the COVID-19 pandemic. Cancer care teams and the patients they serve are navigating significant barriers to high-quality care and impossibly difficult choices regarding allocation of potentially life-saving medical resources to critically ill patients.

April 10, 2020

The pre-publication review and dispute process for the Open Payments 2019 program year has begun. Physicians and teaching hospitals may review and dispute any updated records attributed to them until May 15. The Centers for Medicare & Medicaid Services (CMS) will publish its Open Payments program year 2019 data and any updates to previous program years’ data in June 2020.

How to Review Data

April 10, 2020

Alexandria, VA – The American Society of Clinical Oncology (ASCO) today launched the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry) to help the entire cancer community learn about the pattern of symptoms and severity of COVID-19 among patients with cancer, as well as how COVID-19 infections impact the delivery of cancer care and patient outcomes. The registry will collect both baseline and follow up data throughout the COVID-19 pandemic and into 2021.

March 30, 2020

JCO Oncology Practice recently published an article written by the American Society of Clinical Oncology’s (ASCO) Ethics Committee focused on the causes of burnout in oncology as well as intervention methods. The article provides recommendations for individuals, organizations, and the Society to address burnout and ensure delivery of ethical and quality cancer care. 

March 24, 2020

A new study in JCO Oncology Practice (JCO OP) shows that using clinical pathways in an oncology-specific alternative payment model (APM) can help reduce the cost of cancer care.

March 17, 2020

The Department of Health and Human Services (HHS) issued two final rules aimed at improving the interoperability of electronic health records and defining information blocking. The first rule comes from HHS’ Office of the National Coordinator for Health Information Technology (ONC), and the second rule comes from the Centers for Medicare & Medicaid Services (CMS).

March 9, 2020

On March 6, 2020, President Trump signed into law the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020. On January 31, 2020, Health and Human Services (HHS) Secretary Azar declared a public health emergency effective January 27, 2020, affording the Centers for Medicare & Medicaid Services (CMS)  the flexibility to quickly support Medicare beneficiaries.